期刊文献+

抑癌基因MTS1真核表达载体的构建及其在卵巢癌细胞系HO-8910中的表达 被引量:4

Construction of recombinant vector of multiple tumor suppressor 1 and its expression in human ovarian cancer cell line HO 8910
下载PDF
导出
摘要 目的:构建多肿瘤抑制基因1(MTS1)的真核表达载体,将其转入人源性卵巢癌细胞株HO-8910中,并得到稳定表达,为进一步研究其对卵巢癌细胞的影响奠定实验基础.方法:利用BamHⅠ与EcoRⅠ从pUC19-p16质粒上切下MTS1cDNA片段并克隆到真核表达载体pcDNA3上,构建成MTS1真核表达载体pcDNA3-p16;利用脂质体(Fu-GENETM6)介导的基因导入法将pcDNA3-p16导入人源性卵巢癌细胞株HO-8910中;采用ABC法对转染后的不同代数细胞进行免疫细胞化学检测,观察p16蛋白的表达.结果:成功构建了MTS1真核表达载体pcDNA3-p16,并进行酶切鉴定;转染后经G418筛选2wk出现阳性克隆8910-p16,并检测到其中有p16蛋白的稳定表达.结论:成功构建MTS1真核表达载体pcDNA3-p16,并可在人源性卵巢癌细胞株HO-8910中得到稳定表达. AIM: To construct an recombinant vector consisting of pcDNA3 with MTS1 cDNA, transfect the wild type p 16 gene into human ovarian cancer cell line HO 8910 and prove its expression. METHODS: Having constructed an recombinant vector (pcDNA3 p 16) of pcDNA3 with MTS1 cDNA at its Bam H Ⅰ and Eco R Ⅰ sites,we proved the existence of p 16 in pcDNA3 by restriction pattern. Then we transfected the wild type p 16 gene into human ovarian cancer cell line HO 8910 using Lipofectamin(FuGENE TM 6), selected the positive clone 8910 p 16 and 8910 pcDNA3 by G418 and proved the expressions of MTS1 in different generations of 8910 p 16 by immunocytochemical method. RESULTS: We successfully constructed the recombinant vector pcDNA3 p 16. After transfecting it into HO 8910, we have got the positive clone by selecting the cell with G418 for 2 weeks and detected the steady expression of protein p 16 in 8910 p16. CONCLUSION: The recombinant vector pcDNA3 p 16 that we have constructed can be expressed steadily in human ovarian cancer cell line HO 8910.
机构地区 第四军医大学
出处 《第四军医大学学报》 1999年第4期348-350,353,共4页 Journal of the Fourth Military Medical University
关键词 多肿瘤抑制基因 卵巢癌 基因治疗 multiple tumor suppressor 1 ovarian cancer gene therapy
  • 相关文献

参考文献6

  • 1赵温利,田志刚,郭卫星.肿瘤抑制基因p16的研究进展[J].国外医学(肿瘤学分册),1997,24(4):199-201. 被引量:12
  • 2李楠.p16基因与肿瘤[J].国外医学(肿瘤学分册),1995,22(5):257-259. 被引量:17
  • 3赵温利,国外医学.肿瘤学分册,1997年,24卷,4期,199页
  • 4姜泊,分子生物学常用实验方法,1996年,158页
  • 5李楠,国外医学.肿瘤学分册,1995年,22卷,5期,257页
  • 6Li Y,Cancer Res,1994年,54卷,23期,6078页

共引文献26

同被引文献15

  • 1袁建林.多肿瘤抑制基因(MTS1)的发现与研究进展[J].国外医学(泌尿系统分册),1995,15(6):252-254. 被引量:6
  • 2[1] Kamb A, Gruis NA, Weaver-Feldhaus J et al. A cell cycle r egulator potentially involved in genesis of many tumor types [J]. Science, 1994; 264(5157): 436 -440.
  • 3[2] Nobori T, Miura K, Wu DJ et al. Deletions of the cyclin-depende nt kinase-4 inhibitor gene in multiple human cancers [J]. Nature, 1994; 368(6473): 753 -756.
  • 4[4] Hunter T, Pines J. Cyclins and cancer II: Cyclin D and CDK inhibitor s come of age [J]. Cell, 1994; 79(4): 573-582.
  • 5Wu Q,Int J Cancer,1996年,65卷,6期,840页
  • 6Li Y,Cancer Res,1994年,54卷,23期,6078页
  • 7Serrano M,Hannon GJ,Beach D.A new regulatory motif in cellcycle control causing specific inhibltion of cyclin D/CDK4. Nature . 1993
  • 8Noborl T,Miura K,Wu D J et al.Deletion of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancer. Nature . 1994
  • 9Arap W,Nishikawa R,Furnari F B et al.Replacement of thep16/CDKN2 gene suppresses human glioma cell growth. Cancer Research . 1995
  • 10Kamb A,Gruis NA,Jane WF et al.A cell cycle regulator potentially involved in genesis of many tumor types. Science . 1994

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部